A $100 Billion Drug Discount Program Is Finally Facing New Scrutiny

The Quick Take
The federal government is taking a new approach to overseeing one of the country's fastest-growing healthcare programs.
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to Forbes.


